Brief: Zealand Pharma Q3 Operating Loss DKK 461.3 Million

Zealand Pharma A/S

13/11/2025 06:06

Nov 13 (Reuters) - Zealand Pharma A/S ZELA.CO:

OUTLOOK FY OPERATING EXPENSES DKK 2,000-2,300 MILLION

OUTLOOK 2025: NET OPERATING EXPENSES EXCLUDING OTHER OPERATING ITEMS ARE NOW EXPECTED TO BE BETWEEN DKK 2.0-2.3 BILLION

Q3 REVENUE DKK 49.6 MILLION

Q3 OPERATING LOSS DKK 461.3 MILLION

Source text: ID:nGNE6vkG3c

Further company coverage: ZELA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))